There’s more to dietary ingredients’ potential in weight loss than being used to offset side effects of using GLP-1 drugs consumers are prescribed as obesity treatments, Metabolize.Life asserts in licensing two metabolites from Stanford University’s Office of Technology Licensing.
Israel Startup Licenses Stanford Institute Metabolites To Develop Weight Loss Supplements
Israeli startup by biomedical researcher and entrepreneur Morris Laster using research from ChEM-H Institute scholar at Stanford to will develop and market compounds as nutraceuticals to offer an effective, affordable and side-effect-free solution for weight loss.